Observational study finds 22 genes associated with chronic Epstein-Barr virus infection risk — Evidence Review
Published in Nature, by researchers from Baylor College of Medicine
Researched by
— the AI search engine for science
Table of Contents
A new study has linked 22 human genes to an increased likelihood of persistent Epstein-Barr virus (EBV) infection, offering insight into why some people develop EBV-related diseases while most do not. Related research broadly supports the importance of genetic susceptibility in determining chronic EBV outcomes and disease risk, as demonstrated in large epidemiological and mechanistic studies published over the past decade (journal name).
- Large-scale epidemiological studies have established that EBV infection is nearly universal, but only a subset of individuals—potentially those with specific genetic backgrounds—develop chronic illnesses such as multiple sclerosis (MS) or EBV-associated cancers, supporting the new study’s focus on host genetics 1 2 5.
- Several related studies have identified immune system genes, particularly in the HLA region, as key factors influencing EBV antibody levels, infection control, and susceptibility to autoimmune or malignant complications, aligning with the genes highlighted in the new findings 3 11 13.
- The findings build on previous work showing that genetic and environmental factors together modulate the risk of EBV-related diseases, and that ineffective immune control—often determined by host genetics—can drive progression from benign latent infection to severe chronic disease 3 9 13.
Study Overview and Key Findings
Understanding why Epstein-Barr virus, a nearly ubiquitous infection, leads to severe outcomes in only a minority of people has been a longstanding challenge. This study leverages the power of biobank-scale genome sequencing to investigate host genetic factors that predispose individuals to persistent EBV infection and its long-term health consequences. By analyzing discarded viral DNA reads from large biobank datasets, the research identifies not only genetic associations but also clinical links to a range of EBV-related diseases, emphasizing the importance of immune system genetics in mediating chronic infection risk.
| Property | Value |
|---|---|
| Study Year | 2026 |
| Organization | Baylor College of Medicine |
| Journal Name | Nature |
| Authors | Nyeo, S. S., Cumming, E. M., Burren, O. S., Pagadala, M. S., Gutierrez, J. C., Ali, T. A., Kida, L. C., Chen, Y., Chu, H., Hu, F., Zou, X. Z., Hollis, B., Fabre, M. A., MacArthur, S., Wang, Q., Ludwig, L. S., Dey, K. K., Petrovski, S., Dhindsa, R. S., Lareau, C. A. |
| Population | Individuals with Epstein-Barr virus infection |
| Sample Size | 750,000 people |
| Methods | Observational Study |
| Outcome | Association of genes with chronic Epstein-Barr infection |
| Results | 22 genes linked to higher likelihood of chronic Epstein-Barr infection. |
Literature Review: Related Studies
To contextualize these findings, we searched the Consensus database of over 200 million research papers. The following queries were used to identify relevant studies:
- Epstein-Barr virus multiple sclerosis risk
- chronic EBV infection cancer association
- genetic factors Epstein-Barr infection susceptibility
| Topic | Key Findings |
|---|---|
| Why do only some people develop chronic disease after EBV? | - Host genetic factors, especially HLA and immune response genes, strongly influence the risk of developing MS and EBV-associated cancers after infection 2 3 5 11 13. - Ineffective immune control of EBV, often genetically determined, increases risk for persistent infection and chronic disease 3 5 9 13. |
| What is the link between EBV and multiple sclerosis? | - EBV infection is a near-universal prerequisite for MS, with risk rising sharply after seroconversion; those who remain EBV-negative have extremely low risk 1 2 4 5. - Ineffective control of EBV-induced autoimmunity, shaped by both host and viral genetic variation, can dramatically increase MS risk 3. |
| How does chronic EBV infection relate to cancer development? | - EBV is causally linked to several cancers, including Hodgkin lymphoma, nasopharyngeal carcinoma, and gastric cancer; chronic active infection and high viral loads are associated with increased cancer risk 6 7 8 9 10. - Genetic, environmental, and immune factors intersect to determine individual risk of EBV-related cancers 9 10. |
| Which genetic factors influence susceptibility to EBV outcomes? | - Variants in the HLA region and other immune regulatory genes affect EBV antibody levels, infection persistence, and risk of severe complications 11 13 14. - Primary immunodeficiencies affecting T and NK cell function predispose to uncontrolled EBV infection and related diseases 13. |
Why do only some people develop chronic disease after EBV?
The new study’s identification of 22 genes associated with persistent EBV infection aligns with previous research highlighting the critical role of host genetics—particularly immune system genes—in determining long-term health outcomes after EBV infection. This genetic susceptibility helps explain why most people remain asymptomatic, while a minority develop chronic diseases such as MS or cancer 2 3 5 11 13.
- Multiple studies show that specific HLA variants and immune response genes increase the likelihood of chronic EBV infection and disease 3 5 11.
- Ineffective immune control, shaped by host genetics, has been directly linked to higher risks for MS and lymphoproliferative disorders after EBV infection 3 13.
- The combination of genetic, environmental, and clinical risk factors further determines which individuals progress from latent infection to disease 9 13.
- The new findings expand the list of implicated genes, offering a broader genetic landscape underlying persistent EBV infection and its complications 13.
What is the link between EBV and multiple sclerosis?
A consistent theme across studies is that EBV infection is a prerequisite for MS, with the vast majority of MS cases occurring only in those with prior EBV exposure. The risk of MS increases sharply following EBV seroconversion, especially in genetically susceptible individuals, supporting the new study’s focus on host genetic determinants 1 2 4 5.
- A landmark study found a 32-fold increased risk of MS after EBV infection in young adults, while risk was not increased after other viral infections 1.
- MS risk is extremely low among EBV-negative individuals and rises dramatically after infection, especially in those with certain immune gene variants 2 4.
- Ineffective immune responses to EBV, governed by both viral and host genetic variations, can increase MS risk up to 260-fold 3.
- The chronic presentation of EBV antigens by infected B cells is a potential mechanism linking infection to MS development 5.
How does chronic EBV infection relate to cancer development?
Evidence shows that chronic or active EBV infection is a risk factor for several types of cancer, including Hodgkin lymphoma, nasopharyngeal carcinoma, and gastric cancer. High EBV viral loads, sometimes resulting from host genetic predisposition, are associated with an increased risk of malignant transformation 6 7 8 9 10.
- EBV is implicated in the pathogenesis of up to nine distinct human tumors, causing a significant global cancer burden each year 7 10.
- Intragenic EBV deletions and high viral DNA loads are linked to chronic active infection and neoplastic proliferations 6.
- The risk of EBV-associated cancers is influenced by genetic, environmental, and dietary factors, as well as immune status 9 10.
- Systematic reviews and meta-analyses confirm a strong association between EBV infection and increased risk of several cancers 8 9.
Which genetic factors influence susceptibility to EBV outcomes?
Genetic factors—especially within the HLA region and immune regulatory genes—have been shown to shape the body’s immune response to EBV, affecting antibody levels, infection persistence, and risk of disease. The new study’s gene associations build on this established link, suggesting even broader genetic involvement 11 13 14.
- Genome-wide studies have identified HLA class II genes as major loci influencing EBV antibody responses and infection control 11.
- Mutations affecting T and NK cell function can lead to severe EBV infection or chronic active EBV disease, highlighting the role of immune surveillance 13.
- Systematic reviews indicate that HLA and other immune gene variants are associated with EBV seroprevalence and disease risk 14.
- These findings collectively underpin the genetic component of susceptibility to EBV-related complications.
Future Research Questions
Despite significant advances, questions remain about the mechanisms linking genetics, EBV infection, and chronic disease. Future research should address these gaps to clarify causality, identify at-risk populations, and inform prevention or treatment strategies.
| Research Question | Relevance |
|---|---|
| Which specific mechanisms do the 22 identified genes use to influence chronic EBV infection risk? | Understanding molecular pathways will clarify how genetic variation translates to persistent infection and guide potential therapeutic targets 3 11 13. |
| How do host genetic factors interact with viral variants to modulate disease outcomes after EBV infection? | Both host and viral genetics play roles in disease progression; dissecting their interplay is key for predicting risk and personalizing interventions 3 6. |
| What is the prevalence and impact of these risk genes in diverse populations globally? | Most current data are from European-ancestry cohorts; expanding to more diverse populations is essential for generalizability and equity in risk assessment 14. |
| Can early genetic screening identify individuals at high risk for EBV-related chronic disease? | Early identification could enable targeted monitoring or prevention strategies, potentially reducing the burden of MS and EBV-related cancers 2 13. |
| Are therapies targeting EBV or the immune response effective in preventing chronic disease in genetically susceptible individuals? | Exploring preventive or therapeutic interventions for those with high-risk genetic profiles could transform the management of EBV-related diseases 5 13. |